Skip to Content

Stage 2 Menu Measure 1

Next Measure


Objective: Capability to submit electronic syndromic surveillance data to public health agencies, except where prohibited, and in accordance with applicable law and practice.
Measure: Successful ongoing submission of electronic syndromic surveillance data from Certified EHR Technology to a public health agency for the entire EHR reporting period.
Exclusion: Any EP that meets one or more of the following criteria:

  1. Is not in a category of providers who collect ambulatory syndromic surveillance information on their patients during the EHR reporting period.
  2. Operates in a jurisdiction for which no public health agency is capable of receiving electronic syndromic surveillance data in the specific standards required for Certified EHR Technology at the start of their EHR reporting period.
  3. Operates in a jurisdiction where no public health agency provides information timely on capability to receive syndromic surveillance data.
  4. Operates in a jurisdiction for which no public health agency that is capable of accepting the specific standards required by Certified EHR Technology at the start of their EHR reporting period can enroll additional EPs.

CMS Specification Sheet

TennCare Notes

This objective and measure aligns with Menu Measure 10 in Stage 1 Meaningful Use, but the measure advances from performing a test to successful ongoing submission of data. At this time, no public health agency in Tennessee has the capacity to receive syndromic surveillance data from EPs in the standards mandated, but any updates will be listed on this website as Stage 2 approaches.

Federal Regulations Governing This Measure

CMS' Final Rule

§ 495.6(k)(3)(ii) see objective, measure and exclusion above

Standards and Certification Final Rule

§ 170.314(f)(3) Transmission to public health agencies – syndromic surveillance. EHR technology must be able to electronically create syndrome-based public health surveillance information for electronic transmission in accordance with:
    A. The standard specified in § 170.205(d)(2).
    B. Optional. The standard (and applicable implementation specifications) specified in
         § 170.205(d)(3).

§ 170.205(d)(2) Standard and implementation specifications. Eligibility inquiry and response transactions between dispensers and Part D sponsors for Part D prescription drugs must be conducted in accordance with 42 CFR 423.160(b)(3)(ii). (3) Standard and implementation specifications. A health care claims or equivalent encounter information transaction as defined at 45 CFR 162.1101 must be conducted in accordance with 45 CFR 162.1102(b) or for the period on and after January 1, 2012, in accordance with 45 CFR 162.1102(c).

§ 170.205(d)(3) HL7 2.5.1 (incorporated by reference in § 170.299). Implementation specifications. PHIN Messaging Guide for Syndromic Surveillance (incorporated by reference in § 170.299) and Conformance Clarification for EHR Certification of Electronic Syndromic Surveillance, Addendum to PHIN Messaging Guide for Syndromic Surveillance (incorporated by reference in § 170.299).